Indication

Crohn's disease

Crohn’s disease is a chronic inflammatory bowel disease characterized by progressive, transmural inflammation that can involve any portion of the gastrointestinal tract, most commonly affecting the terminal ileum and colon. Read more about Crohn's disease

502 drugs 186 manufacturers

Advertisement

Drugs that treat it

Common Crohn's disease therapies.

Showing 352–360 of 502 drugs

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
BIONPHARMA INC.

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
KEY THERAPEUTIC

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
CAMBRIDGE THERA

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
DENTON PHARMA I
Filter & compare in the drug finder →Opens the drug finder with Crohn's disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Crohn's disease.

Crohn’s disease is a chronic inflammatory bowel disease characterized by progressive, transmural inflammation that can involve any portion of the gastrointestinal tract, most commonly affecting the terminal ileum and colon.

It typically follows a relapsing and remitting course marked by patchy "skip lesions," abdominal pain, chronic diarrhea, fatigue, and weight loss.

Pathophysiologically driven by immune dysregulation, genetic susceptibility, and environmental factors, the transmural nature of the inflammation frequently leads to structural complications such as strictures, fistulas, abscesses, and bowel obstructions.

Personalize your experience

Follow Crohn's disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it